Comparative efficacy of buparvaquone and imidocarb in inhibiting the in vitro growth of Babesia bovis is a research paper published in Frontiers in Pharmacology (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
BLRD VA
Grant: I01 BX004522
National Institutes of Health
Grant: 1R01AI141412-01A1
Development of a Sustained Release Injectable Formulation for Long-Term Delivery of ELQs
National Institutes of Health
Grant: 5R01AI100569-12
Novel Therapeutics to Target Parasite Cytochrome bc1
FWCI
2.83
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals